Cargando…
Activatable molecular agents for cancer theranostics
Theranostics that integrates diagnosis and treatment modalities has attracted great attention due to its abilities of personalized therapy and real-time monitoring of therapeutic outcome. Such a theranostic paradigm requires agents to simultaneously possess the capabilities of targeting, imaging, an...
Autores principales: | Zhang, Jianjian, Ning, Lulu, Huang, Jiaguo, Zhang, Chi, Pu, Kanyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145638/ https://www.ncbi.nlm.nih.gov/pubmed/34123034 http://dx.doi.org/10.1039/c9sc05460j |
Ejemplares similares
-
Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer
por: Jiang, Yuyan, et al.
Publicado: (2021) -
Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy
por: Zhang, Chi, et al.
Publicado: (2021) -
Near-infrared fluorescent molecular probes for imaging and diagnosis of nephro-urological diseases
por: Huang, Jiaguo, et al.
Publicado: (2020) -
Near-infrared fluorescence probes to detect reactive oxygen species for keloid diagnosis
por: Cheng, Penghui, et al.
Publicado: (2018) -
Unlabeled aspirin as an activatable theranostic MRI agent for breast cancer
por: Pavuluri, KowsalyaDevi, et al.
Publicado: (2022)